RxDoctor Payments Data

Paula Ricke

Family · Grand Forks, NDNPI 1275916330

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,862 of the $8,683 with a category attached, or 67.5%. Medtronic accounts for 89.1% of it on its own, with 5 other manufacturers making up the rest. Among family clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,683in general payments, 2019–2025

Across 65 payments — averaging $133.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Abbott$502
  • Heartflow, Inc.$281
  • Johnson & Johnson$90
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$41
  • Edwards Lifesciences$30

What the payments were for

  • Travel & lodging$5,86268%
  • Food & beverage$2,82032%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,683 in reported general payments places this provider in the 95th percentile of 496 family providers in North Dakota.

See all family providers in North Dakota

Medicare billing

Part B allowed, 2024
$56,155
Medicare patients
697
Services billed
906

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban542$443,965
XareltoRivaroxaban182$150,653
EntrestoSacubitril/Valsartan29$39,919
Metoprolol Succinate548$8,812
SotalolSotalol Hcl440$7,396
Mexiletine Hcl39$5,569
Diltiazem 24hr Er (Cd)Diltiazem Hcl166$5,020
Flecainide Acetate76$2,825
Amiodarone Hcl118$1,467
Warfarin Sodium102$1,223
JantovenWarfarin Sodium101$1,100
Bumetanide18$921
Potassium Chloride37$730
Losartan Potassium57$644
Metoprolol Tartrate71$452

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$90$150,653182 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 496 family providers in North Dakota.

Other family in Grand Forks

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →